BeOne Medicines Ltd. (HKG:6160)
185.80
+3.20 (1.75%)
Aug 5, 2025, 3:45 PM HKT
BeOne Medicines Market Cap
BeOne Medicines has a market cap or net worth of 283.43 billion as of August 4, 2025. Its market cap has increased by 123.29% in one year.
Market Cap
283.43B
Enterprise Value
271.50B
Revenue
32.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
185.80
Market Cap Chart
Since February 3, 2016, BeOne Medicines's market cap has increased from 6.70B to 283.43B, an increase of 4,132.25%. That is a compound annual growth rate of 48.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 278.50B | 82.30% |
Dec 31, 2024 | 152.77B | 4.09% |
Dec 29, 2023 | 146.76B | -17.60% |
Dec 30, 2022 | 178.11B | -17.96% |
Dec 31, 2021 | 217.12B | 19.19% |
Dec 31, 2020 | 182.15B | 130.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hansoh Pharmaceutical Group Company | 208.22B |
JD Health International | 159.75B |
Innovent Biologics | 158.81B |
Akeso | 136.52B |
Sino Biopharmaceutical | 129.66B |
WuXi Biologics | 127.04B |
CSPC Pharmaceutical Group | 110.44B |
Sichuan Kelun-Biotech Biopharmaceutical | 92.38B |